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ABSTRACT
Candida albicans is an opportunistic fungal pathogen that has the capability to switch
from commensal to pathogen in immunocompromised individuals. Recognition of pathogens,
like C. albicans, during infection is poorly characterized primarily due to the difficulties in
visualizing the host/pathogen interaction without killing the host. Transparent animal hosts, such
as Danio rerio (zebrafish), enable imaging of pathogen recognition while maintaining host
viability. For pathogen recognition, zebrafish likely use immune receptors similar to mammalian
receptors including C-type lectin receptors. Human C-type lectin receptors have already been
shown to be crucial in recognition of fungal pathogens like C. albicans, and our goal is to
identify and characterize cognate receptors crucial for fungal recognition in zebrafish. Here, I
show how I purified fusion proteins of recently identified receptors and began characterizing the
binding of these receptors to Candida albicans. Determining the specificity of these receptors
may enhance our understanding of fungal recognition in the zebrafish host and the evolution of
vertebrate immune receptor specificity. In addition, receptors that bind to C. albicans could be
used as a diagnostic for C. albicans infection in patients.
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INTRODUCTION
i. Overview
Opportunistic pathogens have become a major concern in the realm of infectious disease.
While asymptomatic in healthy individuals, these pathogens have the ability to cause significant
infections in patients undergoing immune-suppressing procedures. Candida albicans is an
opportunistic fungal pathogen that causes diseases ranging from oral thrush to candidemia in
immunocompromised individuals. Recognition of pathogens, like C. albicans, during infection is
poorly characterized primarily due to the difficulties in visualizing the host/pathogen interaction
without killing the host. Transparent animal hosts, such as Danio rerio (zebrafish), are necessary
to accomplish the task of imaging pathogen recognition while maintaining host viability. In
addition to being transparent, zebrafish share genetic relatedness to humans and are easy to
manipulate. For pathogen recognition, zebrafish likely use immune receptors similar to
mammalian receptors: Toll-like receptors, Nod-like receptors, and C-type lectin receptors.
Human C-type lectin receptors have already been shown to be crucial in recognition of fungal
pathogens like C. albicans. The long-term goal of this research is to identify and characterize
potential zebrafish receptors that mediate C. albicans recognition. In addition, we hope these
studies will provide insight into the evolutionary relationship between zebrafish and mammalian
immune systems.
ii. Candida albicans - an opportunistic pathogen
Nosocomial candidemia (Candida in the bloodstream) is an ongoing public health
concern. In 2000, C. albicans accounted for 5 – 10% of all nosocomial bloodstream infections in
acute care hospitals, with a 25% mortality rate (17). The medical costs associated with hospital
acquired candidemia were reported upwards of $34,000 per patient (10,17). Other complications
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from infection with Candida species include oral, gastrointestinal, and vaginal thrush. Ninety
percent of acquired immunodeficiency syndrome patients (AIDS) patients suffer from oral
candidiasis, which is the most common oral manifestation of HIV infection (18). Candida
albicans is also the most common species associated with candidiasis and candidemia (20). C.
albicans has the ability to switch from commensalistic to pathogenic in immunocompromised
hosts (patients with AIDS, undergoing chemotherapy, or receiving immunosuppressant drugs for
organ transplants). Determining the mechanisms of this molecular switch has been an ongoing,
complex process.
C. albicans possesses morphological plasticity, meaning it can exist in yeast,
pseudohyphael, and hyphal forms. Many studies have shown that the hyphal form is responsible
for invasive candidiasis. In murine models, prevention of the filamentous form inhibits C.
albicans growth and hinders dissemination (11). In addition, yeast cells that are engulfed by
macrophages switch to hyphal form to escape the macrophage (13). Alternatively, the yeast form
of C. albicans is responsible for the pathogen’s ability to disseminate and cause secondary
infections (9). Candida’s ability to both invade the mucosal and epithelial barriers and to
disseminate and cause systemic infections makes it very difficult to treat.
iii. Innate immunity and pattern recognition receptors (PRRs)
Introduction of foreign invaders into the human body leads to stimulation of the innate
immune response via pattern recognition receptors (PRRs). These PRRs are displayed on the
surface of specific innate immune cells and bind to pathogen associated molecular patterns
(PAMPs). This PAMP-PRR interaction initiates signaling cascades that elicit a nonspecific
immune response to the invader. PAMPs can be many different things, including carbohydrates,
nucleic acid methylation patterns, lipopolysaccharides, and proteins. There is promiscuity with
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PRRs, meaning many PRRs can recognize different PAMPs and many PAMPs stimulate more
than one PRR. While the response generated is PAMP/PRR specific, it is not specific to the
pathogen and thus does not confer long term immunity.
Pattern recognition receptors are classified based on the class of molecules they recognize
and the type of receptor. These include Toll-like receptors (TLRs), NOD-like receptors (NLRs),
and C-type lectin receptors (CLRs). C-type lectin receptors, which are highly conserved across
the animal kingdom, are typically expressed on myeloid and mucosal epithelial cells (22). All Ctype lectin receptors contain at least one carbohydrate recognition domain (CRD) and can exist
as either a soluble or transmembrane receptor. While there are currently seventeen identified Ctype lectin groups, only those of Groups II, III, IV, V, and VI have shown important roles in
innate immunity. Dectin-I (Group V) and Dectin-II (Group II) are primarily responsible for
recognition of Candida albicans in humans.
The cell wall of C. albicans serves a greater role than just protection against osmotic
offense, and has been shown to be a “dynamic organelle” (7). Approximately 80–90% of the cell
wall are carbohydrates, including β(1-3)-glucan and β(1-6)-glucans, N-acetyl-D-glucosamine,
and mannan. Dectin-I recognizes and binds to β(1-3)-glucans and elicits a proinflammatory
response at the site of infection. By masking β-glucan with mannan, C. albicans is able to evade
immune recognition by Dectin-1. However, Dectin-II, Mincle, and DCSF recognize and bind
mannan and also elicit a proinflammatory response. Due to its dynamic nature and contribution
to virulence, it is important to determine which receptors bind which components of C. albicans
cell wall in the zebrafish model.
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iv. Danio rerio as a research tool to study fungal infection
One of the major difficulties with studying host-pathogen interaction in vivo is the
necessity for a transparent host. For this reason, the zebrafish model is of extreme benefit as
opposed to using the murine model. Using the zebrafish larval model allows for real-time
imaging of C. albicans infection, both invasive and disseminated. The other commonly known
benefits of using zebrafish are their genetic relatedness to humans, large brood size, short
generation time, and ease of care and genetic manipulation. Zebrafish are also one of the smallest
animal models with both an innate and adaptive immune system (15). The greatest advantage in
studying the innate immune-fungal interaction is that zebrafish only have an innate immune
system until they reach adulthood (4–6 weeks post fertilization). Since C. albicans recognition in
humans is a primarily innate response, this makes the zebrafish larval model as an ideal tool for
studying Candida infection.
v. Current and previous research
It has yet to be determined which innate receptors of zebrafish recognize C. albicans.
While the downstream signaling of innate receptors is highly conserved across the animal
kingdom, the extracellular domains of the receptors have evolved rapidly over time. The
evolution of the carbohydrate recognition domain (extracellular portion) of C-type lectin
receptors has been driven by pathogenic evolutionary pressures (3). Only the membraneembedded portion of C-type lectin receptors have been conserved across animal models
including Saccharomyces cerevisiae, Caenorhabditis elegans, and Drosophila melanogaster (8).
The Group V C-type lectin receptors have not been found in teleost fish, suggesting there is not a
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direct Dectin-1 homolog in these fish. While there are Group II C-type lectin receptors in
zebrafish, there has yet to be a Dectin-2 homolog discovered.
It has been documented numerous times that C. albicans recognition in zebrafish is
primarily an innate response. NADPH-oxidase dependent phagocyte recruitment during early
infection is a critical requirement for pathogen clearance (4). Neutrophil recruitment during early
infection is needed to prevent filamentous growth which causes invasive candidiasis (16). For
this reason, the purpose of this study has been to identify innate receptor(s) that are responsible
for recognition in zebrafish to further the understanding of C. abicans infection in this animal
model.
The beginnings of this project were conducted by Erin Carter of the Wheeler lab. Using
sequence homology, several potential fungal recognition receptors were identified (Fig. 2). Of
these, seven receptors were cloned for further studies. The following is the name of each of the
receptors and the recognition done by the human ortholog. Dendritic cell-specific intercellular
adhesion molecule-3 grabbing non-integrin like F (DCSIGN-F or DCSF) recognizes highmannose-containing glycoproteins (14). Cluster of Differentiation 209 (CD209) binds
carbohydrate ligands on various microbial surfaces including C. albicans (5). There is no human
homolog, of dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin like
G (DC-SIGN-like-G or DSLG) but it is related to human DCSIGN, also known as CD209 (2).
Zebrafish killer cell lectin 1B (KCL) shares homology with human CD209 (6). Immune-related
lectin-like receptor 1 (ILLR1) possesses an activation motif typically seen in Group V natural
killer T-cell receptors (19). Asialoglycoprotein receptor 2 (ASGPR2) binds to galactaose residues
located on microbial surfaces (12). Salmon C type Lectin Receptor A (SCLRA) shares the most
homology to human Dectin-1 (6).
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All seven identified receptors were cloned into plasmids with a secretion tag (Fig. 3).
This was done by fusing the carbohydrate recognition domain (CRD) to the constant portion of
human Fc. The construct contained a pSecTag2 secretion tag which ensured that the protein
would be secreted by cells expressing the plasmid. In addition, the receptors were labeled with
GFP for fluorescence detection. Following creation of these soluble constructs, the plasmids
were transfected into the HEK293T cell culture line. Secreted protein was collected, purified to
contain only the receptor, and concentrated. Prior to the research discussed in this thesis, five of
the receptors had been purified in this manner.
The research discussed in this thesis begins with purification of the remaining two
receptors, ILLR1 and ASGPR2. Following this, characterization using luminescence binding
assays were conducted on four previously purified receptors. These studies were done to build
upon the fluorescence microscopy experiments conducted by Riju Shresta, who did her capstone
in the Wheeler Lab. The goal of this thesis research has been to determine the binding affinities
of the zebrafish receptors to C. albicans using luminescence high-throughput binding assays.
This information will contribute to a broader understanding of innate immune recognition of C.
albicans in the zebrafish model. In addition, this will allow for in vivo studies to be conducted to
corroborate the results found.

MATERIALS AND METHODS
i. Cell Culture Maintenance
A Steril Gard II laminar flow hood was used to prevent contamination while conducting
the cell culture procedures. HEK293T (Human Embryonic Kidney) cell line was used and grown
in T75 flasks that were placed in a 37ºC incubator for overnight storage. When the HEK293T
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cells reached approximately 90% confluence, as determined by viewing under an inverted
dissecting microscope, the cells were split to double the original number of flasks. Minimum
essential medium supplemented with 10% filter-sterilized FBS, 1µM sodium pyruvate, and 1%
gentamyacin (to prevent contamination) was used for the cells. HEK293T cells are adherent
cells, so the media (~20mLs) was pulled off without disturbing the cells. 4 mL of 0.5% trypsinEDTA (Gibco by Life Technologies) was added to the flask to un-adhere the cells. The flask
containing trypsin was incubated for 5 minutes at 37ºC. Following this incubation period, 16 mL
of fresh media was added to the flask. The fresh media, now containing the HEK293T cells, was
pulled off and transferred to a 50 mL falcon tube. This tube was centrifuged at 1,000rpm for 3
minutes using a Sorvall ST16 centrifuge (Thermo Fisher Scientific). The pelleted cells were then
resuspended in fresh culture media. Using 2 new T75 flasks, 2mL of the resuspended cells were
placed in 18 mL of fresh media for each of the flasks. These flasks were then incubated at 37ºC
until reaching confluence, at the process was repeated.

ii. Polyplus Transfection of HEK293T cells using jetPRIME
HEK293T cells were transfected using a Polyplus jetPRIME transfection kit. HEK293T
cells were taken out of liquid nitrogen storage and grown in a T75 flask. The cells were split into
two T75 flasks following the procedure for Cell Culture Maintenance. This was done to ensure
the freshly thawed cells would grow properly before conducting a transfection. Media was
removed from the flasks, and the HEK293T cells were trypsinized. Following the trypsinization
incubation, 16 mL of fresh media was added and the media, now containing the cells, was
transferred to a 50 mL falcon tube. Following centrifugation at 1,000 rpm for 3 minutes, the
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pelleted cells were resuspended in 4 mL of fresh media and transferred to a new T75 flask. An
additional 6 mL of fresh media was added, to bring the total volume to 10 mL.
In a microcentrifuge tube, 500 µL of jetPRIME buffer, 10 µg of receptor DNA (Table 1),
and 30 µL of jetPRIME reagent were combined. The microcentrifuge tube was then vortexed for
10 seconds and short spun in a centrifuge. This reaction was allowed to incubate at room
temperature for 10 minutes. 200 µL of this transfection mixture was added to the T75 flask
containing HEK293T cells. The flask was incubated at 37ºC. Since the soluble receptor
constructs induce Zeocin resistance, Zeocin was added the day following transfection to select
only transfected cells. Transfections were carried out for approxiametly 4-5 weeks to ensure a
stable line had been created.

Name
Receptor

of

Concentration
(ng/µL)

Amount Added
(µL)

ILLR1

775.8

12.9

ASGPR2

187.7

53.6

Table 1. Concentration of Receptors

iii. Bioreactor Collection of Solubilized Protein
Since the receptors contain a SecTag that allows them to be secreted from the HEK293T
cells, a CellLINE bioreactor was used to collect large amounts of protein. Using a
hemocytometer, cell count was determined of the transfected cells. The desired concentration
was 2.5 x 106 cells/mL to be placed into the bioreactor. This volume of cells was added to 10 mL
of “special media” which contained 10% low IgG FBS instead of 10% HI-FBS. This media
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containing the transfected cells was placed into the inner compartment of the biorecactor. 100
mL of regular media was placed into the outer compartment of the bioreactor along with 1 mL of
Zeocin (to maintain selection). Every 7 days, the media was collected from the small
compartment and spun down. The supernatant containing the soluble protein was kept and stored
at -20ºC until the time came for protein purification. The bioreactor was maintained for 5-6
weeks to ensure adequate protein collection.

iv. Receptor Protein Purification
Transfected HEK293T supernatants were thawed to room temperature prior to
purification. Receptor purification was done using a Hitrap-Protein A column (GE Healthcare).
Hitrap-Protein A column was also brought to room temperature prior to use (stored at 4ºC when
not in use). The column was prepared using a 10 mL syringe loaded with 10 mL of binding
buffer (1x PBS). The syringe was attached as recommended by the manufacturer with a luer lock
adaptor that was also connected to the Protein A column. The flow through was collected in a 50
mL waste Falcon tube. To prevent the introduction of an air bubble, the syringe was
disconnected from the adaptor when ~0.5mL of binding buffer remained. Between each loading
step, a drop of 1x PBS was added to the top of the column to prevent drying the column. After
the column was prepped, a syringe loaded with 10.5 mL of receptor supernatant was applied to
the column, stopping at 0.5 mL as before. The flow rate was kept at a constant 1-2 mL per
minute. The column was then washed with 10 mL of binding buffer (1x PBS). Following this
washing step, 5.5 mL of elution buffer (100mM glycine, 150mM NaCl, 0.05% NaN3, pH 2.8)
was loaded into a syringe and 5 mL was pushed through the column. The flow through was
collected in a clean 15 mL falcon tube containing 0.75 mL neutralizing buffer (1M Tris, pH 9). A
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final washing step with 1x PBS was conducted before the column was placed in a 15 mL Falcon
tube containing 1x PBS.

v. Dialysis of Purified Receptor Protein
The purified eluate was dialyzed against 1x PBS using a Slide-a-lyzer 20,000 MWCO
cartridge (Thermo Scientific). A plastic beaker was filled with 1 liter of 1x PBS. The Slide-alyzer cartridge was soaked in the beaker of 1x PBS for 3 minutes before being loaded with the
purified eluate using a syringe and 18 gauge needle. After the sample was loaded, the syringe
and needle was used to remove any air from the inside of the cartridge. The cartridge was
attached to a floatation device and placed back in the beaker containing 1x PBS along with a stir
bar. This beaker was placed on a stir plate at 4ºC. After one hour of dialysis, the 1 liter of PBS
was replaced with a fresh liter of PBS. Dialysis was then allowed to continue overnight. The
following day, the sample was removed using a syringe and 18 gauge needle and transferred into
a 15 mL Falcon tube to be left on ice.

vi. Centrifugal concentration of dialyzed protein receptors
The dialyzed receptor protein was concentrated using 4 Amicon Ultra 0.5 mL 3k
membrane microconcentrators (Millipore). To each of the microconcentrators, 500 µL of
receptor protein was added. The microconcentrators were centrifuged at 14,000xg for 30 minutes
at 4ºC. The microconcentrators were hen inverted and transferred to new microcentrifuge tubes.
These were spun at 1,000xg for 2 minutes. This process was repeated until the dialyzed protein
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was at a volume of approximately 500 µL. After concentration, 1 volume of 90% glycerol was
added to the samples (final concentration of 45% glycerol). To prevent protein degradation, a
Pierce protease inhibitor mini tablet, EDTA-free (Thermo Scientific) was added at a final
concentration of 1x. The samples was then stored at -20ºC.

vii. Bradford Assay to Determine Protein Concentration
A Bradford Assay was conducted to determine the concentration of the purified receptor
protein. 10 2-fold serial dilutions were made of bovine serum albumin (BSA) by adding 25 µL of
BSA to 25 µL of 45% glycerol + PBS (what the receptor samples are stored in). This dilution
was made 10 times down to a concentration of 9.7 x 10-3 µg/µL. Using a 96-well plate, 10 µL of
the BSA dilutions were added to respective wells in duplicates. 10 µL of 45% glycerol + 1x PBS
was placed in two other wells for duplicate blanks. Two, two-fold dilutions (1:1 and 1:3
dilutions) were made of the concentrated receptor proteins in 1x PBS. 10 µL aliquots of the
undiluted receptor protein, the 1:1 dilution, and the 1:3 dilution were added in duplicate to the
96-well plate. To each of the wells containing protein (BSA or receptor), and the blanks, 90 µL
of Bradford solution was added using a multi-channel pipette. The 96-well plate was allowed to
sit for 10 minutes at room temperature on a plate revolving apparatus. Absorbance readings were
then taken at 595 nm using a plate reader.
A Bradford standard curve was created using the 10 BSA dilution readings, blank
subtracted (BSA A595 – 1x PBS A595). A linear regression line was created using Excel, and the
protein concentrations of the receptor samples were calculated from the linear equation.

viii. Validation of Protein Purification via SDS-PAGE and Western Blot
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A SDS PAGE was first conducted to separate the protein based on size. Samples were
prepared by adding approximately 1µg of protein to SDS-PAGE preparation buffer (40%
Glycerol, 240 mM Tris/HCl pH 6.8, 8% SDS, 0.04% bromophenol blue, 5% betamercaptoethanol). The samples, including an aliquot of Kaleidoscope standard, were boiled for 5
minutes before being centrifuged for 10 seconds. A TGX (tris-glycine) precast gel was added to
the gel holder. 10µL of sample was loaded to each well: ASGPR2, ILLR1, Dectin-1 (positive
control), and 2 wells of Kaleidoscope standard (Figure 1A). SDS-PAGE buffer was added to the
gel compartment. The gel was run for ~50 minutes at 200V to allow for size separation.
After SDS-PAGE, the proteins were transferred to a nitrocellulose membrane and
assayed using a Western Blot. The Ready Gel Blotting Sandwich was arranged as according to
Bio-Rad’s instructions (Figure 1B). This sandwich was soaked in Towbin buffer (tris base and
glycine), before being run at 25V for 20 hours. The following day, the nitrocellulose membrane
now containing the protein, was washed in TBS for 5 minutes (200mM tris and 500 mM NaCl).
To prevent any nonspecific binding, the membrane was blocked for 1 hour in blocking solution
(40 mL TTBS with 2g of nonfat milk) at room temperature. Following blocking, antibody
staining was conducted using 0.04ng/mL HRP-conjugated goat anti-human IgG (Jackson
ImmunoResearch) for 30 minutes at room temperature. The membrane was then washed 4 times
in TTBS, 5 minutes per wash, to remove any excess blocking solution or secondary antibody.
Western Blotting Chemiluminescence Substrate was added before the membrane was imaged.
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Figure 1. Western Blot was conducted to confirm protein purity. (A) Kaleidoscope
standard used for protein size in SDS-PAGE. (B) Bio-Rad Western Blotting Sandwich
arrangement. Image sources: Bio-Rad (A); ThermoFisher Scientific (B).
ix. High-Throughput Luminescence Staining
Wildtype-EGFP (WT-EGFP) and KAH3-EGFP C. albicans strains were streaked for
isolation onto YPD plates (2% Bacto Peptone, 1% Bacto Yeast Extract, 2% Glucose, 2% Bacto
Agar) and grown for 2 days at 37ºC. A single colony of WT-EGFP and a single colony of
KAH3-EGFP were each inoculated into 3 mL of YPD. 1:100 inoculums were done of each by
taking 200 µL of the original inoculum and adding it to 1.98 mL of YPD. The original inoculums
and the 1:100 inoculums were incubated overnight at 30ºC in a roller drum.
The following day, 1 mL of each overnight inoculum was spun down for 30 seconds at
21,000 xg. The cells were then washed three times with 1 mL of 1x PBS, before being
resuspended in 1 mL of 1x PBS. To determine cell count, an OD50 reading was taken. The
spectrophotometer was blanked used 1 mL of 1x PBS. Each sample was diluted 1:100 by adding
10 µL of sample to 990 µL of 1x PBS. The volume of the sample to be added to 8 mL of RPMI
was calculated using the following equation:
(x mL of 1:100)(OD50)(107)(100) = (8 mL RPMI)(desired cell concentration)
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Using a multichannel pipette, 160µL of C. albicans in RPMI was added to each of the
wells in a 96-well cell binding plate. The plate was sealed and incubated at 37ºC for 3-4 hours to
allow cell adherence. Following this incubation period, the cells were washed three times using
100 µL of 1x PBS. Cells were blocked for 30 minutes at room temperature using 100 µL of 1x
PBS + 2% BSA. Cells were washed three times with 1x PBS. Addition of 50 µL of receptor at a
desired concentration was added to all wells except for those chosen to be no-receptor negative
controls. Receptor binding occurred at room temperature for 1 hour. After receptor binding, cells
were washed three times with 1x PBS. Addition of 50 µL of Biotin-SP-conjugated AffiniPure
Donkey Anti-Human IgG FC (Jackson ImmunoResearch) took place for 20 minutes on ice.
Following 2º antibody addition, cells were washed three times with 1x PBS. Streptavidin-HRP
was added for 20 minutes on ice. Cells were washed three more times with 1x PBS. Using a plate
reader, a GFP read was taken of the 96-well plate. A 1:1 dilution of Western Blot Substrate dark
solution to bright solution was created. PBS was removed from the wells and 50 µL of this
luminescence substrate was added. A luminescence read was then taken using the plate reader.

RESULTS
i. Overview
Zebrafish have proven to be an extremely useful model for studying infection with the
opportunistic fungal pathogen Candida albicans. While it has been demonstrated that candidiasis
in zebrafish leads to a primarily innate immune response, the receptors involved in recognition
have yet to be determined. This project has been focused on answering this question, with the
goal of furthering understanding of candidiasis in this animal model. The work discussed in this
thesis picks up with expression and purification of two potential zebrafish receptors to allow for
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receptor purification. Following purification, screening for receptor binding to C. albicans was
conducted using high-throughput luminescence binding assays.

ii. Expression of zebrafish receptors was achieved using Polyplus Transfection
To identify potential targets for zebrafish pattern recognition receptors, we sought to test
the ligand specificity of purified soluble versions of the receptors. Previous work led to the
cloning of seven zebrafish Type II C-type lectin carbohydrate recognition domains (CRDs) in a
mammalian expression vector. The carbohydrate recognition domains of two zebrafish receptors,
ILLLR1 and ASGPR2, had been previously cloned into a mammalian expression vector and these
could then be stably transfected into HEK293T cells. HEK293T (Homo sapiens Embryonic
Kidney) cells are widely used for various cell culture applications. They have the benefits of
being adherent, making passaging easy, and transfect very rapidly. The expression constructs
used contained the CRD region of the desired receptor, a secretion tag, the constant portion of
human IgG Fc, and a gene encoding for zeocin resistance (Fig. 3). The secretion tag allowed for
receptor secretion from transfected HEK293T cells. By fusing the CRD to the constant portion of
human IgG Fc, the same purification and secondary antibody for receptor screening could be
used for all the receptors including the positive control. Lastly, zeocin resistance allowed for
positive selection of transfected cells by eliminating nontransfected cells.
Upon transfection, a stable cell line was created by positive selection with zeocin
antibiotic. Positive selection initially led to decreased observed growth rate because the majority
of cells were killed and HEK293T cells require growth factors from neighbors to grow normally.
Thus, cells were allowed to grow for several weeks until they returned to normal growth rate,
ensuring the cell line was stable. To make certain the cell line wasn’t just evolving from a subset
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of inherently zeocin resistant cells, a negative control was conducted at the same time with nontransfected HEK293T cells being treated with the same amount of zeocin as transfected cells.
Negative controls typically died within a few days after zeocin treatment had begun (Table 3-6).
Two different transfection protocols were conducted to express the receptor constructs.
Originally, two AMAXA nucleofections (Table 2) were conducted with the ILLR1 receptor
construct. However, the cell populations never recovered from the nucleofections. Next, a
jetPRIME Polyplus transfection protocol (Fig. 4) was tried with the ILLR1 receptor construct.
The first attempt didn’t survive, but the second attempt was successful at creating a stable
transfected cell line (Table 3). Some of the transfected cells were frozen down and these were
maintained in a CELLine bioreactor (Fig. 5) for 6 weeks. The transfected cells were placed in a
small compartment and media was placed in a large compartment of the bioreactor. A low
molecular weight filter allowed for passage of nutrients and waste but excluded secreted proteins
from leaving the small compartment. This allowed for protein concentration and samples were
taken out every week for purification. Due to the success of the jetPRIME Polyplus transfection,
this protocol was used for expression of the ASGPR2 receptor construct (Table 4-6). A stable line
was created and maintained for several weeks before being placed in a bioreactor for 7 weeks
(Table 6).

iii. Purification of zebrafish receptors was achieved using HiTrap Protein A Columns
Since HEK293T cells secrete proteins other than the receptors, and the growth media
contains some bovine proteins, protein purifications were conducted on samples taken from the
bioreactor. The secreted protein was applied to a HiTrap Protein A column. Protein A is a
surface protein found on Staphylococcus aureus that binds to the constant portion of human Fc
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(fused to the receptor CRD of the expression constructs). The HiTrap columns were prepared by
washing with phosphate buffer solution (PBS). The supernatants of the bioreactor samples were
applied to the column to allow the lysate to bind to the Protein A. Any unbound protein was
washed off using PBS before an elution buffer was applied. This buffer is highly basic which
leads to a conformational change and release of the lysate. The purified protein was dialyzed
against PBS to remove the elution buffer and was then concentrated. Bradford assays suggest
there was enough protein produced and purified for subsequent analysis (Table 7).

iv. Western Blot was performed to determine purification quality
An SDS-PAGE was performed to separate purified protein based on molecular weight.
This was followed by a Western Blot to transfer purified protein onto a Western Blot membrane.
Immunodetection was done on the Western Blot membrane to determine if the purified protein
was the desired receptor. The expected molecular weights of Dectin-1 is 49.4 kDa, ILLR1 is
45.1, ASGPR2 is 47.6 kDa, and IgG Fc alone is 27.3 kDa. However, the immunodetection results
(Fig. 6) show lower molecular weights for ILLR1 and ASGPR2. The bands are around 27 kDa,
which is the molecular weight of Fc alone. This result suggests that only the Fc portion purified
of the ILLR1 and ASGPR2 receptor constructs. A proteolytic cleavage event likely occurred,
separating the Fc and CRD portions.

v. Development of a high-throughput screening assay for measuring binding of CRD-Fc fusions
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Previous screenings done with the purified zebrafish receptors utilized fluorescence
microscopy. While this technique is useful for visualization, the goal of this part of the project
was to obtain large amounts of quantifiable data. Fluorescence microscopy has very low
throughput, thus in order to determine binding affinities for each of these receptors a higher
throughput protocol needed to be used. Previous research in the Wheeler Lab using 96-well
CellBIND plates for screening antifungal compounds against C. albicans proved to be an
efficient screening method with a large output. CellBIND plates are adherent, which allow the C.
albicans to bind to the plate with minimal disruption from continued pipetting. Based on these
previous studies, a protocol using CellBIND plates was developed to screen the binding affinities
of several receptors at once.
In order to determine the optimal conditions for these screens, numerous optimization
experiments were conducted with the positive control CRD-Fc fusion, Dectin-1-CRD-Fc. Two
GFP labelled C. albicans strains were used: wildtype and KAH3. KAH3 is a strain that has a
mutated cell wall with decreased mannan allowing β-glucan to be exposed. By using KAH3 and
wildtype, the type of carbohydrate the zebrafish receptor binds to can be inferred (mannan versus
β-glucan). KAH3 also allows for detection of other layers of the cell wall besides the top most
mannan layer in wild type C. albicans. Dectin-1 is a β-glucan receptor, thus higher levels of
binding to the KAH3 strain should be seen, creating an additional parameter to determine the
accuracy of the screen. For all the high-throughput experiments discussed in this thesis, C.
albicans was incubated in the CellBIND plates for 3-4 hours. This length of time was previously
determined to be sufficient for cell adherence to the wells. The optical density at 600 nm
absorbance was used to achieve the desired C. albicans concentration.
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a. HRP-conjugated α-human IgG leads to excess background signal
Based on previous studies and for simplification, an Horseradish Peroxidase (HRP)
conjugated α-human IgG secondary antibody (Fig. 7) was first used to detect C. albicans-bound
receptors. Following an incubation with bovine serum albumin (BSA) to prevent non-specific
binding, Dectin-1 and HRP-conjugated α-human IgG were added to the wells. This secondary
antibody was found to have limitations, however. A high enough concentration of secondary
antibody to bind to the Dectin-1 provided too high of a background luminescence. The data was
analyzed by taking the luminescence read (corresponds to amount of secondary antibodyreceptor bound to the C. albicans) and dividing this by the GFP read (amount of C. albicans in
the respective well). A difference in LUM/GFP could be seen as the secondary antibody
concentration increased, but no significant difference could be seen with increasing C. albicans
concentration (Fig. 8). For this reason, an alternate secondary antibody was needed to eliminate
background luminescence that significantly inhibited screening purposes.

b. Biotinylated α-human IgG allows for more specific luminescence detection of Dectin-1
In order to decrease background luminescence from a high HRP concentration, a
biotinylated α-human IgG secondary antibody was used. In addition, this antibody allows for
bivalent interactions with receptors to increase avidity of the antibody-receptor complex.
Streptavidin has an extremely high affinity for biotin, and was thus used to bind to the
biotinylated α-human IgG (Fig. 9). A higher secondary antibody concentration could then be
used when followed by binding with a lower concentration of Streptavidin conjugated with HRP.
The optimal concentration of biotinylated α-human IgG and streptavidin was determined based
on which concentration showed a higher luminescence of Dectin-1 with KAH3 as opposed to

	
  

19	
  

wild type. Initially, very high dilutions were made (1:100 – 1:500 biotinylated α-human IgG and
1:500 – 1:1,000 streptavidin-HRP), however these were not concentrated enough for detection.
Upon further experimentation, the optimal concentration of biotinylated α-human IgG was
determined to be a 1:20 dilution of the secondary antibody (Fig. 10A). The optimal concentration
of streptavidin-HRP was determined to be a 1:100 dilution (Fig. 10B). These concentrations
were used for the remainder of the high-throughput luminescence binding assays discussed in
this thesis.

vi. High-throughput luminescence screening suggests candidate receptors for zebrafish C.
albicans recognition
After determining the optimal protocol for the high throughput luminescence screen, the
four candidate zebrafish receptors were tested (KCL, DCSF, CD209 and DSLG). DCSF did not
appear to recognize either wild type or KAH3 C. albicans (Fig. 11A). KCL showed minimal
recognition of the KAH3 strain. CD209 showed similar recognition to both wild type and KAH3
strains. DSLG showed significant recognition of the wild type strain and minimal recognition of
the KAH3 strain (Fig 11A). None of the zebrafish receptors reached the level of Dectin-1
recognition in either the wild type (Fig. 11B) or KAH3 (Fig. 11C) strains of C. albicans.

DISCUSSION
i. Overview
Recognition of Candida albicans leads to a primarily innate immune response in a human
host. In order to study this recognition, the zebrafish larval model is used because zebrafish
possess only an innate immune system until adulthood. The receptors that recognize C. albicans
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in zebrafish have yet to be determined, although this information is necessary to fully understand
the infection within this model. In addition, this information could provide insight into the
evolution of vertebrate innate immunology and the characteristics of the zebrafish innate immune
system as a model for studying mammalian innate immunity. In continuation of a previous
project aimed at identifying these cognate receptors, I attempted to purify two zebrafish C-type
lectin receptors. I also worked to develop a high throughput method for determining binding
affinities of these receptors to C. albicans that can be easily adapted to detecting binding
affinities for other microbes. These early studies suggest that DSLG and CD209 have the
capacity to recognize C. albicans.

ii. Transfection of HEK293T cells can be used to express zebrafish receptors
HEK293T cells are widely used for protein production, have a high efficiency for various
types of transfection, and reproduce easily and rapidly (21). This cell line was ideal for our
purposes of expressing receptor constructs in high volumes. While two different transfection
protocols were attempted, Polyplus jetPRIME transfection reagent was the most efficient
transfection protocol. Another benefit of the HEK293T cell line for our purposes is that the cells
are adherent, and thus were very easy to passage. This especially was useful when the transfected
cells were placed into a bioreactor, and allowed us to routinely remove the secreted protein
without disturbing the living cells. Based on these results, the Polyplus jetPRIME transfection
protocol and CELLine bioreactors can likely be used for future expression and concentration of
other zebrafish proteins.

iii. Immunodetection reveals the receptor constructs were not fully purified
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Based on the expected molecular weights of ILLR1 and ASGPR2, it does not appear that
the receptor constructs were purified fully. The transfection protocol was used previously by
another student and led to the purification of two of the other receptor constructs (CD209 and
DSLG), and thus it is unlikely that the transfection was unsuccessful. In addition, looking at the
time it took the negative control to die (only a few days), it is highly unlikely that the cells
evolved from a subset of inherently zeocin resistant cells. The HiTrap purification, dialysis, and
concentration protocols were identical to those used for purification of all of the other receptor
constructs. It is possible that a protease was introduced, and led to the degradation of part of the
protein. However, the fact that all three proteins are at approximately the same weight even
though the purifications were done at very different times suggests this is unlikely as well.
It appears that protein was purified that contains the human IgG Fc region, but it isn’t
possible to determine whether there was something else present before the purification. The
sequence of the expression constructs will have to be double-checked to ensure that there wasn’t
an issue with the constructs. After that, the only other possibility would be that proteolytic
cleavage occurred at some point leading to the separation of the CRD and Fc regions of the
protein. The secondary antibody used for the western blot, goat α-human IgG-HRP, binds to the
Fc portion. Any other protein present will not be detected by immunodetection, and thus another
type of protein quantification test would have to be used (i.e. coomassie blue).

iv. High-throughput luminescence assays can be used to measure binding of CRD-Fc fusions
Developing a high-throughput luminescence assay protocol allowed for rapid detection of
receptor binding interactions with C. albicans. This type of screen is necessary to obtain large
amounts of quantifiable data, which can’t be done using fluorescence microscopy and also
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eliminates user bias. Using Dectin-1, a known receptor for C. albicans in humans, the optimal
conditions for the assay could be determined. Originally, goat α-human IgG-HRP secondary
antibody was used because it was the same one used in the Western Blot. However, to reach a
high enough concentration of secondary antibody for detectable interaction with the bound
receptors, the HRP background signal was too high and interfered with interpretation of results.
Although using a biotinylated secondary antibody and streptavidin conjugated with HRP
made a more complex interaction, it allowed for an increased secondary antibody concentration
without increasing the HRP concentration. This decreased the background signal and helped with
interpretation of results. Using both the wild type and KAH3 strains of C. albicans allowed us to
use Dectin-1-Fc as a positive control. KAH3 has a mutated cell wall with the outer mannan layer
removed and the inner layers of the cell wall (including β-glucan) exposed. Knowing that
Dectin-1 is a receptor for β-glucan, the optimal conditions could be determined by which
concentrations led to the biggest increase in luminescence of Dectin-1 bound to KAH3 as
opposed to wild type.
Two of the purified zebrafish receptors showed apparent recognition of C. albicans using
the optimized high-throughput luminescence assay. Luminescence was seen in both the wild type
and KAH3 strain with CD209. DSLG only appears to recognize wild type C. albicans. While
neither luminescence signal was as strong as Dectin-1, these results do suggest that these
receptors are worth further characterization.

v. CD209 in humans recognizes various microbes including C. albicans
Both of the zebrafish receptors that showed binding, CD209 and DSLG (DC-SIGN-likeG) are related to CD209 in humans, which is also known as DCSIGN. The human homolog of
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CD209 has been shown to recognize various microbial ligands of bacteria, viruses, and parasites.
Zebrafish Human CD209 recognizes several Candida species, although the ligand that CD209
binds has yet to be determined (5). In a study to determine the extent to which pathogens have
exerted selective pressure on CD209 in humans, it was found that CD209 has undergone a strong
selective constraint (Barreiro, 2005). Thus, it is likely that recognition of pathogens, including C.
albicans, by zebrafish CD209 and DSLG will be similar to that of CD209 in humans.

vi. Current and future research
In order to confirm the results seen with the first luminescence assays, these experiments
are being repeated to create a larger sample size. Based on sequence homology, it is highly likely
that CD209 and DSLG will recognize C. albicans, but there isn’t enough data to confirm this at
this point. A set of experiments that will be conducted to help form a hypothesis would be to
introduce excess ligand into the assay. For example, by adding excess β-glucan to the wild type
CD209 assay, if there is decreased signaling this would suggest β-glucan could be the ligand
CD209 binds to.
Following quantification using the conditions discussed in this thesis and excess ligand
assays, visualization of this interaction will need to be recorded. Fluorescence microscopy on its
own isn’t sufficient for determining binding affinities, but it can certainly be used to collaborate
quantified data. In addition, microscopy will be the most likely method to observe the binding
interaction in vivo. Taking this to the zebrafish model will be the final step in characterization of
the role of these receptors in C. albicans recognition. Thus having record of what this interaction
looks like in vitro will make in vivo observations easier. Morpholinos are a very common and
easy way to knockdown genes in zebrafish and could be used to knockdown the genes encoding
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for CD209 or DSLG. Comparing cytokine expression of control and knockdown zebrafish would
demonstrate the downstream signaling effects of recognition by the receptors.
It is highly unlikely that all of the purified receptors recognize fungal pathogens.
Fortunately, adapting the high-throughput luminescence assay to detection of other microbes
would be relatively simple. As long as the microbe being tested is adherent, the assay will remain
the same. Determining the specificity of these receptors for various microbes will provide
important information for understanding zebrafish innate immunity. Comparing sequence
homology of these receptors to human innate immune receptors and the results observed from
the binding assays will give insight into how vertebrate innate immunity has evolved from teolest
fish to mammals.

vii. Conclusion
Candida albicans is the third leading cause of nosocomial infections in hospitalized
patients in the United States. This opportunistic pathogen can cause various infections, including
lethal invasive candidiasis in immunocompromised patients. In order to develop treatments for
C. albicans infection, the role of specific immune cells in recognition needs to be characterized.
The larval zebrafish model is ideal for studying C. albicans infection, because they only possess
an innate immune system. However, in order to understand how C. albicans is recognized in this
model, the receptors involved need to be elucidated. The goal of this research project has been to
determine which zebrafish C-type lectin receptors bind to C. albicans. This project also has two
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broader implications: understanding how vertebrate innate immunology has evolved from teolest
fish to humans and assessing the benefit of using zebrafish for fungal immunology research.
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TABLES
Experiment Started
Experiment
terminated
Zeocin added
Negative
control
died
Not determined
Container

N.D.
Surface
Area
2.0 cm2
1 24-well plate well
2
3.7 cm
1 12 well plate well
9.61 cm2
1 6 well plate well
2
75 cm
T75 flask
Key for Table 2 (below)
Day

	
  

AMAXA Nucleofection
ILLR1 Attempt 1

AMAXA Nucleofection
ILLR1 Attempt 2

28	
  

Cell Container/
Surface Area
1 75cm2 flask
2 75cm2flasks
3 9.61 cm2 wells
3 9.61 cm2 wells
3 9.61 cm2 wells
3 9.61 cm2 wells
6 9.61 cm2 wells
6 9.61 cm2 wells
6 9.61 cm2 wells

Confluence

Cell Container/
Confluence
Surface Area
-2
90%
1 75cm2 flask
90%
-1
Split
2 75cm2 flasks
Split
2
0
N.A.
3 9.61 cm wells
N.A.
1
40%
3 9.61 cm2 wells
N.D.
2
2
60%
3 9.61 cm wells
40%
3
90%
3 9.61 cm2 wells
N.D.
2
4
Split
6 9.61 cm wells
Split
2
5
30%
6 9.61 cm wells
50%
6
40%
10
9.61cm2
Split
wells
7
6 2.0 cm2 wells
Condensed
10
9.61cm2
70%
wells
8
6 2.0 cm2 wells
N.D.
1 75cm2 flask
Combined
2
2
9
6 2.0 cm wells
40%
6 9.61 cm
Condensed
wells
10
6 2.0 cm2 wells
40%
12 3.7 cm2
Condensed
wells
11
6 2.0 cm2 wells
20%
12 3.7 cm2
30%
wells
12
6 2.0 cm2 wells
Cells died
12 3.7 cm2
N.D.
wells
13
12 3.7 cm2
Cells died
wells
Table 2. AMAXA Nucleofection was unsuccessful at expressing the ILLR1 receptor
construct in the HEK293T cell line. In an attempt to create a stable cell line expressing the
ILLR1 receptor construct, two AMAXA Nucleofections were attempted.

Experiment started
Experiment
terminated
Zeocin added
Negative
control
died
Bioreactor started
Cells frozen down
Thawed
frozen
cells
N.D.
Not determined
Key for Tables 3-6 (below)
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Day

Polyplus Transfection
ILLR1 Attempt 1
Number of TConfluence
75 Flasks
1
40%
1
80%
1→2
Split
2
40%
2
Cells died

Polyplus Transfection
ILLR1 Attempt 2
Number of T-75
Confluence
Flasks
-1
1
40%
0
1
80%
1
1→2
Split
2
2
N.D.
3
2
70%
4
2→4
Split
5
4
40%
6
4
N.D.
7
4→8
80%
8
8 → 10
Two were split
9
10
40%
10
10 → 5
Condensed 6 to
1
11
5 → 10
Split
12
10
70%
13
10
90%
14
2→4
Two not frozen
down were split
15
4
N.D.
16
4→8
Split
17
8
40%
18
8
70%
19
8 → 16
Split
20
16
50%
21
16
90%
22
4
Froze down all
but 4
23
4 →8
Split
24
8
Bacterial
Contamination
25
1
Thawed
cells
from freezer
26
1
50%
27
1→2
Split
28
2
60%
29
2→4
Split
30
4
Placed
in
Bioreactor
Table 3. Polyplus Transfection was successful at expressing the ILLR1 receptor
construct in the HEK293T cell line. The second attempt at using the Polyplus transfection
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protocol was successful at creating a stable cell line expressing the ILLR1 receptor construct. The
transfected cells were placed into a CellLINE bioreactor to concentrate the secreted protein.

Day

Polyplus Transfection
ASGPR2 Attempt 1
Number of T-75
Confluence
Flasks
1
40%
1
80%
1→2
Split
2
40%
2
70%
2→4
Split
4
30%
4
N.D.
4
40%
4
40%

-1
0
1
2
3
4
5
6
7
8
	
  

Polyplus Transfection
ASGPR2 Attempt 2
Number of T-75
Confluence
Flasks
1
40%
1
80%
1→2
Split
2
N.D.
2
60%
2→4
Split
4
40%
4
30%
4→2
Condensed
2
30%
31	
  

9
10
11
12
Table

4→1
Condensed
2
Cells Died
1
30%
1
20%
1
Cells Died
4. Polyplus Transfection was initially unsuccessful at expressing the ASGPR2

receptor construct in the HEK293T cell line. In the initial attempts to transfect HEK293T with
the ASGPR2 receptor construct, the cells didn’t make it through the positive selection phase.

Day

-1
0
1
2
3
4
5
6
7
8

Polyplus Transfection
ASGPR2 Attempt 3
Number of TConfluence
75 Flasks
1
40%
1
80%
1→2
Split
2
40%
2
N.D.
2
20%
2
Cells Died

Polyplus Transfection
ASGPR2 Attempt 4
Number of T-75
Confluence
Flasks
1
40%
1
80%
1→2
Split
2
40%
2
80%
2→4
Split
4
40%
4
N.D.
4→8
80%
8
N.D.

Experiment Note: trypsin volume
wasn’t high enough to remove cells
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from flask
9

3→2

Froze down 5
flasks
10
2
30%
11
2
Bacterial
contamination
12
1
Thawed
Vial
from freezer
13
1
Bacterial
contamination
14
1
Thawed another
vial from freezer
15
1
Bacterial
Contamination
16
Experiment Note: Killed experiment
and threw out remaining vials in the
17
freezer; likely contamination came before
18
freezing
Table 5. Bacterial contamination killed cells transfected with the ASGPR2 receptor
construct. Introduction of a bacterial contaminant inhibited the generation of a stable ASGPR2
transfected cell line.

Day

-1
0
1
2
3
4
5
6
7
8
	
  

Polyplus Transfection
ASGPR2 Attempt 5
Number of TConfluence
75 Flasks
1
40%
1
80%
1→2
Split
2
40%
2→4
Split
4
50%
4→8
Split
8
N.D.
8
50%
8
70%
33	
  

9
10
11

8 → 16
16
1

Split
60%
Froze down 15
flasks
12
1
N.D.
13
1→2
Split
14
2
50%
15
2→4
Split
16
4
60%
17
4
Placed
in
Bioreactor
Table 6. An ASGPR2 transfected HEK293T cell line was created using the Polyplus
Transfection protocol. The final attempt at transfecting cells with the ASGPR2 receptor
construct was successful. The transfected cells were placed into a CellLINE bioreactor to
concentrate the secreted protein.

Receptor
ILLR1 Purification #1

Concentration
0.459 mg/mL

ILLR1 Purification #2

0.236 mg/mL

ASGPR2 Purification #1

0.34 mg/mL

Table 7. Bradford assays suggest there was enough purified protein for subsequent
analysis. Bradford assays were conducted to determine the concentration of purified protein.

	
  

34	
  

FIGURES

	
  

35	
  

Figure 2. Association between various C-type lectin receptors. Image shows C-type lectin
receptors belonging to group II (red), group V blue), NK-like receptors (green) in Danio rerio
(Dre), Takifugu rubripes (Tru), Salmo salar (Ssa), Gallus gallus (Gga), Mus musculus (Mmu),
and Homo sapiens (Hsa) aligned using Clustal W. The zebrafish receptors are highlighted in
yellow. (Source: Erin Carter unpublished thesis, 2014)
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Figure 3. Generation of plasmids containing zebrafish receptor carbohydrate recognition
domain. Previous work done by Erin Carter of the Wheeler Lab led to the generation of seven
zebrafish receptor constructs. The carbohydrate recognition domain (CRD) of each zebrafish
receptor was fused with the constant portion of human IgG Fc, a gene coding for zeocin
resistance, and a secretion tag.
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Figure 4. Polyplus Transfection was used to express the ILLR1 and ASGPR2 receptor
constructs in HEK293T cells. The transfection protocol was divided into two parts: initial
transfection with jetPRIME reagents and the plasmid DNA containing the receptor constructs;
positive selection for transformed cells using zeocin. Cells were placed in a bioreactor for
collection of secreted protein. A no DNA transfection was used as a negative control.
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Figure 5. CELLine bioreactor was used to concentrate transfected HEK293T secreted
protein. The transfected HEK293T cells are placed in a small compartment in the bioreactor
which is separated from the large compartment holding cell culture media by a low molecular
weight filter. This filter allows for passage of nutrients and waste but inhibits secreted protein
from exiting the small compartment. The secreted protein becomes concentrated and was
removed every week for purification. Image source: The Lab Depot.
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Figure 6. Immunodetection of ILLR1 and ASGPR2 receptor constructs suggests that the Fc
portion was all that was purified. An SDS-PAGE and Western Blot were conducted to
determine if the protein expression and purification was successful. By looking at the
corresponding molecular weights of the Kaleidoscope standard, it appears that only the Fc
portion was purified of the ILLR1 and ASGPR2 receptor constructs.
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Figure 7. HRP conjugated α-human IgG secondary antibody was initially used for
detection of Dectin-1-Fc in high-throughput luminescence screen. Initially, an HRP
conjugated α-human IgG secondary antibody was used to detect levels of Dectin-1-Fc binding to
wild type and KAH3 strains of C. albicans. BSA was used to prevent any nonspecific receptor
binding. Addition of a western blotting substrate leads to a chemical reaction with the HRP that
allows for chemiluminescence screening.
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Figure 8. Increased secondary antibody concentration leads to apparent increase in
detection of Dectin-1-Fc binding. By increasing the HRP conjugated a-human IgG
concentration, there is an increase in level of luminescence per GFP. However, increasing the C.
albicans concentration shows no significant difference in luminescence in either the wild type
(A) or KAH3 (B) strains (the legend corresponds to cells/mL). This suggests that the increased
secondary antibody concentration is providing excess background luminescence and false
positive reads.
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Figure 9. Biotin conjugated α-human IgG secondary antibody was used for detection of
Dectin-1-Fc in high-throughput luminescence screen. A biotin conjugated α-human IgG
secondary antibody was used to detect levels of Dectin-1-Fc binding to wild type and KAH3
strains of C. albicans. BSA was used to prevent any nonspecific receptor binding. Streptavidin
conjugated with HRP (has a strong affinity for biotin) was used for chemiluminscence detection
when treated with a western blotting substrate.
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Figure 10. A 1:20 dilution of biotin conjugated with α-human IgG secondary antibody (A)
and a 1:100 dilution of streptavidin conjugated with HRP (B) showed the greatest
difference in luminescence between wild type and KAH3 strains of C. albicans. In order to
determine the optimal concentrations of secondary antibody and streptavidin-HRP, the
luminescence of Dectin-1 binding to wild type and KAH3 strains of C. albicans were compared.
Dectin-1 is a receptor for β-glucan, which is more exposed in the KAH3 mutant strain than the
wild type. Thus, the optimal concentrations were determined to be 1:20 of secondary antibody
and 1:100 of strepatividin-HRP because these concentrations showed the greatest increase in
luminescence in the KAH3 strain compared to the wild type strain.
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Figure 11. High-throughput luminescence screen shows significant recognition of C.
albicans by two candidate zebrafish receptors. (A) CD209 showed similar recognition of wild
type and KAH3 strains of C. albicans. DSLG showed higher recognition of wild type strain than
KAH3. KCL and DCSF didn’t appear to recognize C. albicans. (B) Of the zebrafish receptors,
CD209 and DSLG showed the highest recognition of the wild type strain. (C) Of the zebrafish
receptors, CD209 showed the highest recognition of the KAH3 strain. Three experiments
consisting of quadruplicate wells for each sample condition were conducted (n = 12). Error bars
represent standard error.
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